throbber
JOURNAL OF
`PHARMACEUTICAL
`SCIENCES @
`
`DECEMBER 1982
`VOLUME 71 NUMBER 12
`
`RESEARCH ARTlCL ES
`
`Effects of Surfactants on the Aqueous Stability and
`Solubility of P-Lactam Antibiotics
`
`AKIRA TSUJI *x, ETSUKO MIYAMOTO $, MUNEAKI MATSUDA *,
`KEIKO NISHIMURA *, and TSUKINAKA YAMANA 8
`Received June 8,1981, from the *Faculty of Pharmaceutical Sciences and +Hospital Pharmacy, Kanazauia University, Takara-machi,
`Kanazari'a 920, Japan, and the 'School of Pharmacy, Hokuriku University, Kanagawa-machi, Kanazaula 920-11, Japan.
`Accepted for
`publication February 4, 1982.
`
`Abstract 0 Studies were undertaken to elucidate the interaction be-
`tween (3-lactam antibiotics and surfactant micelles and to examine the
`effects of surfactants on their aqueous stability and solubility. The ap-
`parent binding constant of the micelle-antibiotic complex was deter-
`mined as a function of the solution pH at 37' and p = 0.15 by the dynamic
`dialysis method and hydrolysis study. In the interaction with nonionic
`and anionic micelles of polyoxyethylene-23-lauryl ether (I) and sodium
`lauryl sulfate (111, large differences were noted in the binding constants
`between the undissociated and ionized species of penicillins. However,
`the cat ionic surfactants, cetyltrimethylammonium bromide (111). showed
`no significant difference in the binding constants for both species. Acid
`degradation of penicillins was protected in micellar solutions of I and 111
`but was facilitated in micelles of 11. The surfactants exerted no influence
`011 the neutral degradation of the antibiotics used. The solubilization of
`penicillin V acid by micelles of I was studied at pH 2.0 and 35". The sol-
`ubility increased threefold in the presence of 10 mM I.
`Keyphrases Antibiotics, /3-lactam-effects
`of surfactants on the
`aqueous stability and solubility, interactions with surfactant micelles
`0 Surfactant micelles-effects on the aqueous stability and solubility
`of @-lactam antibiotics 0 Binding constant-interaction
`between
`8-lactam antibiotics and surfactant micelles, aqueous stability and sol-
`ubility
`
`The interaction of surface-active agents with drugs is
`of theoretical and practical importance, since such sur-
`factants represent one of the most important groups of
`adjuvants in pharmaceutical preparations. Surfactants
`incorporated in the drug dosage form are able to influence
`the drug stability and dissolution as a result of drug-sur-
`factant micellar interactions.
`So far there have been only a few reports on the inter-
`action (1-3) between P-lactam antibiotics and surfactant
`micelles. Recently, a catalytic effect of cationic surfactants
`on the degradation of cephalexin at neutral pH by en-
`trapment of the antibiotic micelles was described. No ef-
`fects on the cephalexin stability, however, were observed
`in anionic micelles (2).
`
`The aims of the present study were to elucidate the en-
`trapment of penicillin and cephalosporin antibiotics into
`the micelle of various types of surfactants as a function of
`the solution pH, and to investigate the effects of the anti-
`biotic-micelle interaction on the stability and solubility
`of these antibiotics under a gastric pH environment. A
`preliminary report has already been published (3).
`
`EXPERIMENTAL
`Materials-Antibiotics-The
`following (3-lactam antibiotics were
`used as supplied: propicillin potassium' (993 pg/mg), penicillin V po-
`tassium2 (1490 U/mg), and cefazolin sodium:l(966 Fg/mg). Free acid of
`penicillin V was obtained from a commercial source4.
`ether (I), sodium lauryl
`Surfactants-Polyoxyethylene-23-lauryl
`sulfate (II), and cetyltrimethylammonium bromide (111) were obtained
`from commercial sources and used without further purification except
`11. Compound I1 was recrystallized according to the literature (4).
`Chemicals-All other chemicals employed were of reagent grade and
`used without further purification except imidazole. Imidazole was re-
`crystallized from benzene followed by a thorough washing with ether.
`and penicillin V were determined
`Analytical Procedures-Propicillin
`by the spectrophotometric method developed previously (5). No influence
`of surfactants in this assay was observed. The concentration of the an-
`tibiotic in the samples was calculated from a calibration curve prepared
`daily. Cefazolin was analyzed in the stability experiment by reversed-
`phase high-performance liquid chromatography (HPLC). The liquid
`chromatograph5 was equipped with a UV detector6 set at 254 nm. The
`stationary phase was octadecylsilane chemically bonded on totally porous
`silica gel, prepacked into a 125-mm stainless steel column7 (4.6-mm i.d.).
`The mobile phase was 10% (v/v) acetonitrile-0.01 M ammonium acetate.
`The instrument was operated at ambient temperature and at a flow rate
`
`~~
`
`Takeda Chemical Industries, Osaka, Japan.
`* Banyu Pharmaceutical Co., Osaka, Japan.
`Fujisawa Pharmaceutical Co., Osaka, Japan.
`Sigma Chemical Co., St. Louis, Ma.
`Model FLC-A700, Japan Spectroscopic Co., Tokyo, Japan.
`Model UVIDEC-100, Japan Spectroscopic Co., Tokyo, Japan.
`SC-01, Japan Spectroscopic Co., Tokyo, Japan.
`
`0022-3549/82/1200- 13 13$01.00/0
`@ 1982, American Pharmaceutical Association
`
`Journal of Pharmaceutical Sciences I 1313
`Vol. 71, No. 72, December 1982
`
`Opiant Exhibit 2309
`Nalox-1 Pharmaceuticals, LLC v. Opiant Pharmaceuticals, Inc.
`IPR2019-00685, IPR2019-00688, IPR2019-00694
`Page 1
`
`

`

`0.21
`
`I
`2
`
`4
`
`I
`8
`
`10
`
`6
`HOURS
`Figure 2-First-order plots for the dialysis of propicillin in the presence
`of surfactants of various pH ualues at 37" and = 0.15. Key: 1 (control,
`M II, pH 6.50); 3 (2 X
`M I , pH 6 SO); 4 (3 X
`pH 6.50), 2 (4 X
`10-2MII,pH4.00);.5(2.4X 10-3MIII,pH4.00);6(4 X 1 0 - 2 M I , p H
`M I , pH 3.00); 8 (6.9 X
`4.00); 7 (1.5 X
`M III, pH 6.50).
`
`Figure I-Apparatus
`for the dynamic dialysis experiment. Key: (A)
`control motor; (B) sampling hole; (C) thermostated water bath; (0)
`jacketed beaker; (E) dialysis membrane; and (F) stirring shaft.
`
`of 1.0 ml/min, and then samples were injected through a 100-pl injectorR.
`The peak heights were used for quantification.
`Procedure-Dynamic Dialysis-The method employed was essen-
`tially the same as that described previously (6). The apparatus used in
`this study is illustrated in Fig. 1. The system consisted of a jacketed
`beaker (500 ml) set in a thermostated water bath. Three hundred milli-
`liters of buffer solution (ionic strength 0.15) was placed in the beaker. A
`cellulose tubeg was knotted at one end to form a bag (length 10 cm) and
`attached with a rubber band to the glass tubing with a stirring shaft. Eight
`milliliters of antibiotic buffer solution with or without surfactants was
`placed into the bag. The bag attached with a stopper was fitted on the
`beaker. Both the inner and outer solutions were stirred. All experiments
`were carried out at 37 f 0.1" and at various pHs with phosphate, acetate,
`and citrate buffer systems maintained at an ionic strength of 0.15. At
`appropriate time intervals, aliquots (10 ml) of the outer solution were
`withdrawn and 10 ml of drug-free buffer solution preheated at 37" was
`added. The samples were analyzed by the spectrophotometric method
`or HPLC described in the previous section. The concentration of the
`outer solution samples was corrected as follows:
`5 (cl1)i-l
`+ (vs/v11)
`( c I I ) n =
`,=1
`
`where (CII), and (CII):~~ represent the true and observed concentrations
`of t.he nth sample from the outer solution, respectively, and V,$ and V11
`represent the sampling volume and volume of the outer solution, re-
`spectively.
`Degradation Kinetics-Unless otherwise stated, kinetic studies were
`carried out at 37 f 0.1' and an ionic strength of 0.15. Each antibiotic was
`dissolved in hydrochloric acid-potassium chloride aqueous solution with
`or without surfactant to give a final antibiotic concentration of 6 X 10-4
`M . A saturated solution of the antibiotic was sometimes used because
`of limited solubility. At appropriate time intervals, aliquots were with-
`drawn, cooled, and analyzed. The pseudo first-order rate constants, kdeg,
`were calculated by least-squares analysis of the slopes of plots between
`the logarithm of the antibiotic concentration and time.
`Solubility Measurement-An excess of penicillin V (acid form) was
`added to the hydrochloric acid-potassium chloride solution (pH 2.0 and
`ionic strength 0.5) in a glass-stoppered flask. The flask was placed in a
`thermostated water bath at 35 f 0.1" and shaken mechanically until the
`antibiotic concentration in the solution showed an equilibrium value. A
`sample was taken through a 0.45-pm membrane filterlo and, if necessary,
`assayed after appropriate dilution with distilled water. The pH of the
`sample solution was measured" before use and at the end of the experi-
`ment; no significant change was observed.
`Determination of Critical Micelle Concentration-The determination
`of the critical micelle concentration (CMC) was accomplished by deter-
`
`(Eq. 1)
`
`8 Model LP1-350, Japan Spectroscopic Co., Tokyo, Japan.
`9 Visking dialysis membrane, Union Carbide Corp., Chicago, 111.
`lo Sartorius-memhranfilter, GmbH, 34 Gottingen, West Germany.
`l1 PHM26 pH-meter, Radiometer, Copenhagen, Denmark.
`
`1314 I Journal of Pharmaceutical Sciences
`Vol. 71, No. 12, December 1982
`
`mining the concentration at which the break in the log concentration
`uersus surface tension plot occurs. The surface tension of surfactant so-
`lutions of ionic strength of 0.15 containing various concentrations of I,
`11, or I11 and the antibiotic at the concentration used for dialysis and
`degradation studies was determined at 37" by a Du Nouy tensiom-
`eterI2.
`
`RESULTS
`Kinetics of Dynamic Dialysis-For quantification of the interaction
`between a drug molecule and surfactant micelles, various methods are
`available such as equilibrium dialysis (7), dynamic dialysis (8), micellar
`solubilization (9), the potentiometric titration method (lo), molecular
`sieve (ll), and micellar catalysis kinetics in the drug degradation (9).
`Among these, the dynamic dialysis method provides quick information
`for the existence of the interaction with macromolecules by utilization
`of marked difference of the permeation rate through a dialysis mem-
`brane.
`According to Fick's first law of diffusion, the rate of drug dialysis can
`be expressed by:
`
`(Eq. 2)
`where (CI)T and (CII)T represent the total concentration of the drug in
`the inner and outer solutions of the dialysis bag, respectively. Since the
`present experiments were carried out under the sink condition, (CI)T -
`(CII)T was assumed to be equal to ( C ~ ) T . The apparent first-order dialysis
`rate constant, kdia, therefore, was calculated from:
`
`where Co represents the initial concentration of the drug solution in the
`dialysis bag. The value for ( C I ) T was calculated from the mass balance
`equation as follows:
`
`(Eq. 4)
`where VI and VII represent the volume of the inner and outer solutions,
`respectively. Figure 2 shows typical semilogarithmic plots of the molar
`fraction of propicillin remaining in various surfactant solutions in the
`bag uersus time, and it indicates that the dialysis rates follow first-order
`kinetics in conformity with Eq. 3. Plots of the kdia for propicillin uersus
`the concentration of surfactants are given in Fig. 3 and show a marked
`decrease of kdie with increase in the surfactant concentration and a ten-
`dency to reach constant rate constants. The results apparently indicate
`the occurrence of entrapment of propicillin in the micelles, which are
`difficult to be dialyzed.
`If the drug is incorporated into the micelle, there then will be an
`equilibrium between the drug in solution and that in the micelle. The
`apparent binding constant, Kap,,. can be expressed as:
`
`l2 Du Nouy tensiometer, Shimadzu, Co., Kyoto, Japan.
`
`Opiant Exhibit 2309
`Nalox-1 Pharmaceuticals, LLC v. Opiant Pharmaceuticals, Inc.
`IPR2019-00685, IPR2019-00688, IPR2019-00694
`Page 2
`
`

`

`30
`50
`40
`20
`10
`CONCENTRATION OF SURFACTANT, l o 3 M
`
`Figure 3-Plots of the pseudo first-order rate constant, kdia, versus total
`surfactant concentration for the dialysis of propicillin at 37" and p =
`0.15. Key: (0) I (pH 3.50); (A) II (pH 4.40); (0) I l l (pH 6.50). The points
`are experimental values. The solid curues were generated from Eq. 6
`using the parameters in Table II.
`
`where (Cr), and (CI), represent the concentration of the drug free and
`bound with the surfactant micelle, respectively, and C,g is the total
`concentration of surfactant. When it is assumed that only free drug can
`permeate through the dialysis membrane, Eq. 6 is obtained from Eqs.
`3 and 5:
`
`1
`1 + Kapp (Cn - CMC)
`kdta = ko
`where ko represents the first-order dialysis rate constant of the drug in
`the absence of surfactant. Rearrangement of Eq. 6 gives:
`
`(Eq. 6)
`
`(Eq. 7)
`
`Equation 7 predicts that plots of (kolkdi, - 1) uersus (CO - CMC) passing
`through the origin are linear. The values of CMC used for the calculation
`are 0.092 mM, 0.46 mM, and 0.32 mM for I, 11, and 111, respectively, which
`were determined in this laboratory in the presence of the ant.ibiotic at
`37" and p = 0.15. As illustrated in Fig. 4, the results obtained for propi-
`cillin with various surfactants revealed a linear relationship in accordance
`with Ey. 7. The apparent binding constant, Kspp, was calculated from
`the slopes and the values are listed in Table I. During the periods of the
`dialysis experiments, there was negligible degradat,ion of propicillin.
`pH-Dependency of t h e Apparent Binding Constant in Micelle-
`Antibiotic Interactions-Penicillins have a pKa value of 2.7-2.9 (12)
`and exist in aqueous solutions in undissociated and ionized forms. The
`respective forms may yield different binding behavior in surfactant mi-
`cellar solutions. Figure 5 shows the pH-dependency of Kapp for propicillin
`in solutions of I, 11, and 111 as determined by the dynamic dialysis method.
`Some of the data were those determined in a stability kinetic study, which
`will be described. In the solutions of I and 11, the values of K,,,
`for pro-
`picillin decreased markedly as the pH increased approaching a constant
`value. It is supposed that a considerable difference exists in the micellar
`interactions between undissociat,ed species of propicillin and its ionized
`form. The relationship between the hydrogen ion activity of the bulk
`solution and the apparent binding constant can be represented by (see
`Appendix):
`
`Ka
`+KA-
`O H
`Kdpp = K H A ___
`a ~ + K a
`a H + K a
`where K H A and K A are the binding constants for the undissociated form
`of propicillin and its ionized form, respectively. Incorporation at pKa 2.76
`of propicillin gave parameters of K H A = 489.0 f 27.0 M-' and K A = 40.4
`f 2.7 M-' for I as the best fit to the data using a NONLIN computer
`
`(Eq. 8)
`
`30
`20
`1o3ccD - CMC), M
`Figure 4-Plots according to Ey. 7for the dialysis of cefazolin (Q) and
`propicillin (other symbols) in the presence of I (cirles), I! (triangles),
`and 111 (squares) at various pHs, 37'. and p = 0.15, Key: (0) pH 6.50;
`(m) pH 4.00; (0) pH 3.00; (e) pH 3.50; ( 8 ) pH 4.00; ( 0 ) pH 5.00; ( 0 )
`pH 6.50; (A) pH 6.50; (A) p H 4.00; (A) pH 4.40; (a) pH 3.40 and pH
`6.50.
`
`4%
`
`program (13). The curves in Fig. 5 were generated for I and I1 from Eq.
`8 by the use of these parameters as listed in Table 11.
`In the interaction of propicillin and the micelles of 111, the apparent
`binding constant was virtually independent of the bulk solution pH. This
`indicates no significant difference in the magnitude of KHA and K A , and
`analysis of the data gave K H ~ = K A = 810.1 M-' as the mean of experi-
`mental data at all pH values.
`A similar experiment was also carried out for the interaction between
`cefazolin [pKa = 2.54 (14)) and the micelle of I. The values of Kapp were
`extremely low, being -3 M-' in the wide pH range of 3-7, indicating
`negligible entrapment of the undissociated and ionized cefazolin into the
`micelles of I (Fig. 4).
`Effect of Surfactants on the Stability of the Antibiotics-The
`acid-catalyzed degradation of fl-lactam antibiotics was examined in the
`surfactant solutions of I, 11, and 111 at 37 f 0.1" and an ionic strength of
`0.15. The degradation followed first-order kinetics with regard to the
`antibiotic concentration in all surfactant solutions. Typical results for
`propicillin obtained by linear semilogarithmic plots of the residual molar
`fraction of antibiotic uersus time are shown in Fig. 6.
`As illustrated in Fig. 7, the pseudo first-order rate constant for the
`degradation of propicillin at acidic pH was increased significantly by the
`
`Table I-Apparent Binding Constant, Kapp, between Propicillin
`and Various Surfactants *
`I
`
`111
`
`..
`
`I1
`
`~~
`
`1.10
`4.00
`6.50
`
`856.0h
`793.8
`780.4
`
`175.0b
`1.61
`459.36
`1.10
`119.0h
`2.60
`404.9*
`1.92
`91.3b
`3.00
`247.2
`3.00
`28.5
`3.50
`115.1
`3.50
`20.7
`4.00
`59.5
`4.00
`13.2
`5.00
`42.5
`5.00
`4.0
`6.50
`42.0
`6.50
`0 The values were calculated from the experimental data according to Eq. 7 by
`These values were determined
`the least-squares treatment at 37' and p = 0.15
`in the stabilitv study
`
`~~
`
`~
`
`Journal of Pharmaceutical Sciences 1 1315
`Voi. 71, No. 12, December 1982
`
`Opiant Exhibit 2309
`Nalox-1 Pharmaceuticals, LLC v. Opiant Pharmaceuticals, Inc.
`IPR2019-00685, IPR2019-00688, IPR2019-00694
`Page 3
`
`

`

`I
`4
`
`I
`5
`
`I
`6
`
`1
`
`I
`2
`
`I
`3
`HOURS
`Figure 6-First-order plots for the degradation of propicillin in the
`presence of surfactants at uarious pHs, 37", and p = 0.15. Key: 1 (3 X
`M I I , pH 1.61);2 (control, pH 1.10);3 (4.5 X
`M II, pH 2.50);
`3 ( 1 X 1 0 - 2 M I , p H 1 . 1 0 ) ; 5 ( 8 . 9 X 10-2MIII,pH1.10);6(3.1 X l O - '
`M I , pH 1.92).
`M III, pH 1.10); 7 (1 X
`
`Within an experimental period of <1 day, there was no influence of
`the surfactants on the neutral degradation of the antibiotic used in this
`study.
`Effect of Surfactants on the Antibiotic Solubility-The saturable
`solubility of penicillin V, C,, at pH 2.0 and 35' increased with concen-
`tration of I as shown in Table 111. The data indicated that the aqueous
`solubility of penicillin V increased threefold in the presence of 10 mM
`I at pH 2.0 and 35', showing that penicillins are solubilized by surfactant
`micelles.
`
`DISCUSSION
`Solutions of penicillin G are highly unstable at a gastric pH, the half-
`lives being 1 min at pH 1 and 7 min at pH 2 (15,16). Such chemical in-
`activation of penicillin G in the gastric fluid has been reported to be re-
`sponsible for the poor bioavailability of this antibiotic. The acid degra-
`dation rates of penicillin derivatives are known to depend on their 6-
`sidechain nature due to the rearrangement initiated by the attack of the
`sidechain amidocarbonyl on the P-lactam to produce the corresponding
`penicillenic acid and penillic acid (16).
`Considerable efforts have been made to stabilize acid-labile penicillins.
`Previous authors (17) succeeded in stabilizing potassium salts of penicillin
`G and penicillin V in simulated gastric juice by coating with cholesteryl
`acetate, yielding 1.6- and twofold higher urine levels, respectively, after
`oral administration of these pharmaceutical preparations to humans.
`The previous (3) and present studies revealed a marked stability of
`penicillins in acid solutions with both cationic and nonionic micelles. Four
`kinds of derivatives, penicillin G, penicillin V, phenethicillin, and pro-
`picillin, can be stabilized to maximal extents of 6-, lo-, 8-, and 10-fold
`by the micelles of 111 and of 4-, 6-, 7-, and 13-fold by the micelles of I,
`respectively (3). These stabilization effects are attributed to incorporation
`of the penicillin molecules into both types of micelles. As is apparent from
`these results (3), the apparent binding constant between the penicillins
`and micelles increased with increasing lipophilic character of the peni-
`cillins, as expressed in terms of their octanol-water partition coefficients,
`P (12). This suggests that hydrophobic binding is involved in the inter-
`action between the cationic or nonionic micelle and undissociated species
`of the penicillins. These strong interactions resulted in protection of the
`p-lactam ring sterically and/or electrostatically from intramolecular and
`nucleophilic attack of the sidechain amidocarbonyl oxygen. However,
`it is probable that due to the localized hydrogen ion activity surrounding
`the negatively charged micelle, the anionic micellar state by I1 leads to
`an increase in the rate of degradation. The maximal acceleration of the
`P-lactam cleavage of propicillin by micelles of I1 was predicted to be
`60-fold at pH 1.6 and 37'.
`In contrast to penicillins, the acid degradation of cefazolin, a relatively
`acid-unstable cephalosporin (14), was not influenced by the presence of
`any type of surfactant, like cephalothin described previously (3). This
`was due to the fact that cefazolin was not sufficiently bound to the mi-
`celles, the apparent binding constant being confirmed as almost negligible
`by the dynamic dialysis method (Fig. 4). The very weak interaction of
`
`1
`
`0
`
`1
`
`2
`
`4
`
`5
`
`6
`
`7
`
`
`
`3
`PH
`Figure 5-Plots of the apparent binding constant, K,,,,
`of propicillin
`versus t h e bulk solution pH at 37' and p = 0.15. Key: (0,e) I; (A,&
`I I ; (o,.) I l l ; (open symbols, dynamic dialysis; closed symbols, sta-
`bility).
`
`addition of anionic surfactant (11); whereas, it decreased on increasing
`the concentration of both nonionic and cationic surfactants (I and 111).
`For other penicillins, similar results have been reported (3). In all cases,
`the rate constants first increased or decreased rapidly and then ap-
`proached a constant value above the CMC of the surfactants, suggesting
`the formation of penicillin-micelle complexes.
`According to the literature (9), the apparent first-order degradation
`rate constant thus, is expressed by:
`ko t k,(Cn - CMC)
`1 + Kapp (Cn - CMC)
`kdey =
`Rearrangement of Eq. 9 gives:
`
`(Eq. 9)
`
`Equation 10 predicts that plots of l / ( k o - kdeg) uersus 1 / ( c ~ - CMC)
`should give a straight line from which it should be possible to obtain k ,
`and Kapp values.
`Plots of Eq. 10 for the degradation of propicillin in the presence of I
`and 111 are shown in Figs. 8 and 9, respectively. The values of Kapp for the
`various reaction systems are given in Table I.
`
`Table 11-Binding Constants for Undissociated and Ionized
`Prooicillin with Various Surfactants a
`K H A . M-'
`Surfactant
`I
`489.0 f 27.0
`171.8 f 29.9
`I1
`810.1 f 40.3b
`111
`(I The binding constants were calculated by nonlinear regression program,
`NONLIN, at 37' and g = 0.15. This value is the mean f SD of the experimental
`data.
`
`K a , M-'
`40.4 f 2.7
`4.5 f 1.3
`810.3 f 40.3b
`
`~~~~
`
`1316 I Journal of Pharmaceutical Sciences
`Vol. 71, No. 72, December 7982
`
`Opiant Exhibit 2309
`Nalox-1 Pharmaceuticals, LLC v. Opiant Pharmaceuticals, Inc.
`IPR2019-00685, IPR2019-00688, IPR2019-00694
`Page 4
`
`

`

`3r
`
`1.75
`
`L5
`
`1.25
`
`I
`I
`1
`50
`40
`30
`2 0
`10
`CONCENTRATION OF SURFACTANT, lo3 M
`
`Figure 7-Plots of the pseudo first-order rate constant versus total
`concentration of surfactant for the degradation of propicillin at 37" and
`p = 0.15. Key: (a) I (pH 1.10, left scale); (A) II (pH 3.00, right scale);
`(H) Ill IpH 1.10, left scale). The points are experimental ualues. The
`solid curiies were generated from Ey. 9.
`
`the cefazolin molecule with surfactant micelles undoubtedly is due to the
`low lipid solubility of the antibiotic itself.
`The partitioning behavior of p-lactam antibiotics was investigated (12),
`both in n-octanol-water and isobutyl alcohol-water systems, as a function
`of the aqueous phase solution pH and showed that both the undissociated
`and ionized species could be partitioned into the oil phase, although the
`
`200
`I
`
`400
`1
`
`600
`I
`
`800
`I
`
`1000
`
`1.
`
`0
`
`L z -
`
`m
`
`; . P O
`
`r
`0
`
`0 c - .
`
`&
`
`, pH 1.92
`
`gH
`I11 , pH 1.10
`
`0
`
`reciprocal plots according to Eq. 10 for the degra-
`Figure 8-Double
`dation of propicillin in the presence of I and Ill at 37" and p = 0.15. Key:
`upper and right scales for pH 1.10; loioer and left scalesfor p H 1.92.
`
`15 -
`
`PH 3.00
`
`-
`
`10
`L r
`0 c
`I
`m
`
`U c - . -
`
`5 -
`
`pH 1.61
`i
`
`8 8
`
`4
`6
`4
`2
`6
`2
`1/(cD - CMC), 10-'M-'
`reciprocal plots according to Eq. I0 for the degra-
`Figure 9-Double
`dation of propicillin in the presence o/lI at 37O and p = 0.15.
`
`former was far more lipophilic than the latter. As shown in Fig. 5, the pH
`dependency of the Kapp values in the propicillin interaction with I was
`parallel to that of the apparent partition coefficients in oil-water systems.
`The interactions of propicillin with the micelles of I1 and I11 showed a
`marked contrast in the dependencies of their respective Kal,,, values on
`the pH of the bulk aqueous solution. In the case of the micelle of 11, Kapl,
`clearly decreased as the pH increased, while in the micelle of 111, K,,,
`exhibited independency in the wide pH range betwen 1 and 6. These re-
`sults can be explained on the basis of the participation of electrostatic
`forces between the ionized species of the antibiotic and the ionized sur-
`factant micelles in addition to the hydrophobic contribution.
`Electrical repulsive forces may play a significant, role between ionized
`propicillin and the anionized surfactant micelle to produce the deduced
`K.4 value, as seen from the KHAIKA ratio being -100. Unlike the anionic
`case, the attraction due to the electrostatic forces between the ionized
`form of propicillin and cationic surfactant micelle may lead to an effective
`cancellation of charge within the molecule, resulting in K H A = K.4.
`However, the magnitude of KA is dependent on the differences both 01
`the hydrogen ion activity and the acid dissociation behavior between
`aqueous and micellar phases (see Appendix).
`Based on the present study, it should be emphasized that the acid-
`labile penicillins were significantly stabilized and solubilized by incor-
`porating the unionized species into nonionic surfactant micelles, and the
`penicillin molecules entrapped in the micelle could t,hen be easily released
`at neutral pH values by reducing the force in the interaction between the
`
`Table 111-Solubility of Propicillin in t h e Presence of I a
`Concentration
`Solubility of
`of I,
`Propicillin,
`103 M
`l @ ' M
`0.72
`0.0
`1.21
`3.0
`1.55
`5.0
`7.0
`1.89
`10.0
`2.40
`20.0
`-1.09
`" Values at 37". pH 2.00, and p = 0.5.
`
`Journal of Pharmaceutical Sciences I 13 17
`Vol. 71, No. 12, December 1982
`
`Opiant Exhibit 2309
`Nalox-1 Pharmaceuticals, LLC v. Opiant Pharmaceuticals, Inc.
`IPR2019-00685, IPR2019-00688, IPR2019-00694
`Page 5
`
`

`

`ionized species and micelles. Cephalosporins, which have a much lower
`lipophilicity than penicillins (12), are not incorporated into nonionic
`surfactant micelles, so that there is no significant influence on the
`chemical stability and solubility in aqueous solution.
`
`corporation of the undissociated and ionized forms of drugs into the
`micelles can be calculated, without knowledge of a ~ , , and K,,,,
`from
`the dependence of the bulk aqueous solution pH upon the Kapp
`values.
`
`APPENDIX
`Alteration of the acid dissociation equilibrium of the drug in si:rfactant
`micelles would be in terms of local alteration in hydrogen ion concen-
`tration in the micelles. It is to be expected that the hydrogen ion activity
`(aH,,,,) will be greater near the surface of the anionic micelles and lower
`near the surface of the cationic micelles than that ( a H ) in the bulk
`aqueous phase.
`Assuming that both species of undissociated and ionized drugs which
`exist in the aqueous phase are incorporated into the micellar phase, the
`various equilibria can be described as:
`
`where H A and A refer to the undissociated and ionized species, respec-
`tively, and the subscripts aq and m refer to the aqueous and micellar
`phases, respectively. The other parameters are the same as described in
`the text. It is clear that the KHA/KA = (Ka/Ka,m) from Eqs. AlLA4. The
`apparent binding constant, Kapp, between drugs and micelles is given
`by:
`
`By use of the equilibrium constants defined above, Eq. 8 can be arrived
`at from Eq. A6. Therefore, the binding constants, KHA and K A , for in-
`
`REFERENCES
`(1) F. Alhaique, C. BotrC., G. Lionetti, M. Marchetti, and F. M. Ric-
`cieri, J. Pharm. Sci., 56, 1555 (1967).
`(2) M. Yasuhara, F. Sato, T. Kimura, S. Muranishi, and H. Sezaki,
`J. Pharm. Pharmacol., 29,638 (1977).
`(3) A. Tsuji, M. Matsuda, E. Miyamoto, and T. Yamana, ibid., 30,
`442 (1978).
`(4) J. L. Kurtz, J . Phys. Chem., 66,2239 (1962).
`(5) H. Bundgaard and K. h e r , J. Pharm. Pharmacol., 24, 790
`(1972).
`(6) M. C. Meyer and D. E. Guttman, J . Pharm. Sci., 57, 1627
`( 1968).
`(7) N. K. Patel and N. E. Foss, ibid., 54,1495 (1965).
`(8) A. Agren and R. Elofsson, Acta Pharm. Suec., 4,281 (1967).
`(9) J. H. Fendler and E. J. Fendler, “Catalysis in Micellar and Mac-
`romolecular Systems,” Academic, New York, N.Y., (1975).
`(10) M. Donbrow and C. T. Rhodes, J. Chem. Sci., 1964,6166.
`(11) M. Donbrow, E. Azaz, and R. Hamburger, J. Pharm. Sci., 59,1427
`(1970).
`(12) A. Tsuji, 0. Kubo, E. Miyamoto, and T. Yamana, ibid., 66,1675
`(1977).
`(13) C. M. Metzler, “NONLIN, A Computer Program for Parameter
`Estimation in Nonlinear Systems,” Technical Report 7292/69/7297/005,
`The Upjohn Co., Kalamazoo, Mich.
`(14) T. Yamana and A. Tsuji, J. Pharm. Sci., 65,1563 (1976).
`(15) T. Yamana, A. Tsuji, and Y. Mizukami, Chem. Pharm. Bull.
`(Tokyo), 22,1186 (1954).
`(16) M. A. Schwartz, J. Pharm. Sci., 58, 643 (1969).
`(17) S. P. Patel and C. I. Jarowski, ibid., 64,869 (1975).
`
`ACKNOWLEDGMENTS
`The present results were presented in part at the APhA Academy of
`Pharmaceutical Sciences, 29th National Meeting, San Antonio, Texas,
`November, 1980.
`The authors acknowledge the gifts of P-lactam antibiotics from Takeda
`Chemical Industries, Banyu Pharmaceutical Co., and Fujisawa Phar-
`maceutical Co. The computer analysis was performed on the digital
`computer, FACOM M-160 at the Data Processing Center, Kanazawa
`University.
`
`13 18 I Journal of Pharmaceutical Sciences
`Vol. 71, No. 12, December 1982
`
`Opiant Exhibit 2309
`Nalox-1 Pharmaceuticals, LLC v. Opiant Pharmaceuticals, Inc.
`IPR2019-00685, IPR2019-00688, IPR2019-00694
`Page 6
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket